|
|
Volumn 43, Issue 6, 2002, Pages 1245-1251
|
|
The development of marked elevation in white blood cell count does not predict inferior outcome in chronic lymphocytic leukemia
|
|
Author keywords
Chronic lymphocytic leukemia; Drug treatment; Leukocytosis; Natural history; Survival
|
|
Indexed keywords
ALKYLATING AGENT;
CHLORAMBUCIL;
ADULT;
AGED;
ARTICLE;
CANCER CENTER;
CANCER STAGING;
CANCER SURVIVAL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL FEATURE;
CONTROLLED STUDY;
DATA ANALYSIS;
FEMALE;
FOLLOW UP;
FREQUENCY ANALYSIS;
HUMAN;
LEUKOCYTOSIS;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
SURVIVAL TIME;
TREATMENT INDICATION;
TREATMENT OUTCOME;
BLOOD;
CANADA;
LEUKOCYTE COUNT;
MIDDLE AGED;
MORTALITY;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
RETROSPECTIVE STUDY;
REVIEW;
STATISTICAL ANALYSIS;
SURVIVAL;
ACTUARIAL ANALYSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
LEUKEMIA, LYMPHOCYTIC, CHRONIC;
LEUKOCYTE COUNT;
LEUKOCYTOSIS;
MALE;
MIDDLE AGE;
NEOPLASM STAGING;
ONTARIO;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035992284
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/10428190290026295 Document Type: Article |
|
Times cited : (3)
|
|
References (31)
|
